Hepatitis C Treatment Market Segmented By Hepatitis C Drugs, HCV by HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy, Interferon and Antiviral Drug Class
Industry: Healthcare
Published Date: November-2016
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 168
Report ID: PMRREP3602
1. Executive Summary
2. Assumptions and Acronyms
3. Research Methodology
4. Hepatitis C Treatment Market Overview
4.1. Introduction
4.1.1. Hepatitis C Treatment Market Definition
4.1.2. Hepatitis C Treatment Market - Current treatment options
4.1.3. Hepatitis C Treatment Market Taxonomy
4.1.4. Hepatitis C Treatment Market - Parent Market Overview
4.2. Hepatitis C Treatment Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Pipeline Analysis
4.4. Disease Epidemiology, By Region
5. Global Hepatitis C Treatment Market Analysis Scenario
5.1. Market Value (US$ Mn) Forecast
5.1.1. Y-o-Y Growth Projections
5.1.2. Absolute $ Opportunity
5.2. Hepatitis C Treatment Market Trends
5.3. Regional Average Pricing Analysis (2015)
5.4. Global Hepatitis C Treatment Market Snapshot (2015)
5.4.1. Market Share, By Region
5.4.2. Market Share, By Drug Class
5.4.3. Market Share, By Distribution Channel
6. Global Hepatitis C Treatment Market Analysis, By Drug Class
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Drug Class
6.1.2. Market Share & Basis Point (BPS) Analysis, By Drug Class
6.2. Market Forecast, By Drug Class
6.2.1. HCV Protease Inhibitors
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value (US$ Mn) Forecast
6.2.2. HCV Polymerase Inhibitors
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value (US$ Mn) Forecast
6.2.3. HCV NS5A Inhibitors
6.2.3.1. Absolute $ Opportunity
6.2.3.2. Market Value (US$ Mn) Forecast
6.2.4. Combination Therapy
6.2.4.1. Absolute $ Opportunity
6.2.4.2. Market Value (US$ Mn) Forecast
6.2.4.3. Ledipasvir & Sofosbuvir
6.2.4.4. Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir
6.2.4.5. Elbasvir & Grazoprevir
6.2.4.6. Others
6.2.5. Interferon and Antiviral
6.2.5.1. Absolute $ Opportunity
6.2.5.2. Market Value (US$ Mn) Forecast
6.2.5.3. Peginterferon alfa-2a
6.2.5.4. Peginterferon alfa-2b
6.2.5.5. Ribavirin
6.2.5.6. Others
6.3. Market Attractiveness Analysis, By Drug Class
6.4. Prominent Trends
7. Global Hepatitis C Treatment Market Analysis, By Distribution Channel
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Distribution Channel
7.1.2. Market Share & Basis Point (BPS) Analysis, By Distribution Channel
7.2. Market Forecast, By Distribution Channel
7.2.1. Hospital Pharmacies
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value (US$ Mn) Forecast
7.2.2. Retail Pharmacies
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value (US$ Mn) Forecast
7.2.3. Online Pharmacies
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value (US$ Mn) Forecast
8. Global Hepatitis C Treatment Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Value (US$ Mn) Forecast
8.2.2. Latin America Market Value (US$ Mn) Forecast
8.2.3. Europe Market Value (US$ Mn) Forecast
8.2.4. APAC Market Value (US$ Mn) Forecast
8.2.5. MEA Market Value (US$ Mn) Forecast
8.3. Regional Attractiveness Analysis
9. North America Hepatitis C Treatment Market Analysis
9.1. Introduction
9.1.1. Y-o-Y Growth Projections, By Country
9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
9.2. Key Regulations
9.3. Key Trends
9.4. North America Market Forecast
9.4.1. Market Value (US$ Mn) Forecast, By Country
9.4.1.1. U.S. Absolute $ Opportunity
9.4.1.2. Canada Absolute $ Opportunity
9.4.2. Market Value (US$ Mn) Forecast, By Drug Class
9.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Drug Class
9.5.3. By Distribution Channel
10. Latin America Hepatitis C Treatment Market Analysis
10.1. Introduction
10.1.1. Y-o-Y Growth Projections, By Country
10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
10.2. Key Regulations
10.3. Key Trends
10.4. Latin America Market Forecast
10.4.1. Market Value (US$ Mn) Forecast, By Country
10.4.1.1. Brazil Absolute $ Opportunity
10.4.1.2. Mexico Absolute $ Opportunity
10.4.1.3. Rest of Latin America Absolute $ Opportunity
10.4.2. Market Value (US$ Mn) Forecast, By Drug Class
10.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Drug Class
10.5.3. By Distribution Channel
11. Europe Hepatitis C Treatment Market Analysis
11.1. Introduction
11.1.1. Y-o-Y Growth Projections, By Country
11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
11.2. Key Regulations
11.3. Key Trends
11.4. Europe Market Forecast
11.4.1. Market Value (US$ Mn) Forecast, By Country
11.4.1.1. U.K. Absolute $ Opportunity
11.4.1.2. France Absolute $ Opportunity
11.4.1.3. Germany Absolute $ Opportunity
11.4.1.4. Rest of Europe Absolute $ Opportunity
11.4.2. Market Value (US$ Mn) Forecast, By Drug Class
11.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Drug Class
11.5.3. By Distribution Channel
12. APAC Hepatitis C Treatment Market Analysis
12.1. Introduction
12.1.1. Y-o-Y Growth Projections, By Country
12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
12.2. Key Regulations
12.3. Key Trends
12.4. APAC Market Forecast
12.4.1. Market Value (US$ Mn) Forecast, By Country
12.4.1.1. Japan Absolute $ Opportunity
12.4.1.2. China Absolute $ Opportunity
12.4.1.3. Australia & New Zealand Absolute $ Opportunity
12.4.1.4. Rest of APAC Absolute $ Opportunity
12.4.2. Market Value (US$ Mn) Forecast, By Drug Class
12.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Drug Class
12.5.3. By Distribution Channel
13. MEA Hepatitis C Treatment Market Analysis
13.1. Introduction
13.1.1. Y-o-Y Growth Projections, By Country
13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
13.2. Key Regulations
13.3. Key Trends
13.4. MEA Market Forecast
13.4.1. Market Value (US$ Mn) Forecast, By Country
13.4.1.1. GCC Countries Absolute $ Opportunity
13.4.1.2. South Africa Absolute $ Opportunity
13.4.1.3. Rest of MEA Absolute $ Opportunity
13.4.2. Market Value (US$ Mn) Forecast, By Drug Class
13.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Drug Class
13.5.3. By Distribution Channel
13.5.4. By Disease Indication
14. Competition Landscape
14.1. Competition Dashboard
14.2. Company Profiles Inclusions
14.2.1. Revenue
14.2.2. Products/Brand Offerings
14.2.3. Key developments
14.2.4. SWOT Analysis
14.3. Company Profiles
14.3.1. Gilead Sciences, Inc.
14.3.2. AbbVie Inc.
14.3.3. Kadmon Holdings, Inc.
14.3.4. F. Hoffmann-La Roche Ltd
14.3.5. GlaxoSmithKline plc.
14.3.6. Bristol-Myers Squibb Company
14.3.7. Merck & Co., Inc.
14.3.8. Johnson & Johnson
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 1: Global Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016-2024)
Table 2: Global Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016-2024)
Table 3: Global Hepatitis C Treatment Market Size and Forecast by Region (US$ Mn) (2016-2024)
Table 4: North America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016-2024)
Table 5: North America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016-2024)
Table 6: North America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016-2024)
Table 7: Latin America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016-2024)
Table 8: Latin America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016-2024)
Table 9: Latin America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016-2024)
Table 10: Europe Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016-2024)
Table 11: Europe Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016-2024)
Table 12: Europe Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016-2024)
Table 13: APAC Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016-2024)
Table 14: APAC Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016-2024)
Table 15: APAC Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016-2024)
Table 16: MEA Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016-2024)
Table 17: MEA Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016-2024)
Table 18: MEA Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016-2024)
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 1: Global Hepatitis C Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2024
Figure 2: Global Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 3: Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Drug Class, 2016 & 2024
Figure 4: Global Hepatitis C Treatment Market Y-o-Y growth (%) By Drug Class, 2016-2024
Figure 5: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By HCV Protease Inhibitors
Figure 6: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Protease Inhibitors, 2016-2024
Figure 7: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By HCV Polymerase Inhibitors
Figure 8: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Polymerase Inhibitors, 2016-2024
Figure 9: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By HCV NS5A Inhibitors
Figure 10: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV NS5A Inhibitors, 2016-2024
Figure 11: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Combination Therapy
Figure 12: Global Hepatitis C Treatment Market Absolute $ Opportunity by Combination Therapy, 2016-2024
Figure 13: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Ledipasvir & Sofosbuvir Sub-segment
Figure 14: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir Sub-segment
Figure 15: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Elbasvir & Grazoprevir Sub-segment
Figure 16: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Others Sub-segment
Figure 17: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Interferon and Antiviral
Figure 18: Global Hepatitis C Treatment Market Absolute $ Opportunity by Interferon and Antiviral, 2016-2024
Figure 19: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Peginterferon alfa-2a Sub-segment
Figure 20: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Peginterferon alfa-2b Sub-segment
Figure 21: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Ribavirin Sub-segment
Figure 22: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Others Sub-segment
Figure 23: Global Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
Figure 24: Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
Figure 25: Global Hepatitis C Treatment Market Y-o-Y growth (%) By Distribution Channel, 2016-2024
Figure 26: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Hospital Pharmacies Segment
Figure 27: Global Hepatitis C Treatment Market Absolute $ Opportunity by Hospital Pharmacies Segment, 2016-2024
Figure 28: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Retail Pharmacies Segment
Figure 29: Global Hepatitis C Treatment Market Absolute $ Opportunity by Retail Pharmacies Segment, 2016-2024
Figure 30: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Online Pharmacies Segment
Figure 31: Global Hepatitis C Treatment Market Absolute $ Opportunity by Online Pharmacies, 2016-2024
Figure 32: Global Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
Figure 33: North America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 34: Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 35: Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 36: APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 37: MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 38: Global Hepatitis C Treatment Market Attractiveness Analysis by Region, 2016-2024
Figure 39: North America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 40: North America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
Figure 41: The U.S Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 42: The U.S Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 43: Canada Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 44: Canada Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 45: North America Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
Figure 46: North America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
Figure 47: North America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
Figure 48: Latin America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 49: Latin America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
Figure 50: Brazil Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 51: Brazil Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 52: Mexico Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 53: Mexico Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 54: Rest of Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 55: Rest of Latin America Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 56: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
Figure 57: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
Figure 58: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
Figure 59: Europe Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 60: Europe Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
Figure 61: U.K. Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 62: U.K. Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 63: France Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 64: France Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 65: Germany Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 66: Germany Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 67: Rest of Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 68: Rest of Europe Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 69: Europe Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
Figure 70: Europe Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
Figure 71: Europe Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
Figure 72: APAC Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 73: APAC Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
Figure 74: Japan Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 75: Japan Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 76: China Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 77: China Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 78: Australia & New Zealand Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 79: Australia & New Zealand Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 80: Rest of APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 81: Rest of APAC Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 82: APAC Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
Figure 83: APAC Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
Figure 84: APAC Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
Figure 85: MEA Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 86: MEA Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
Figure 87: GCC Countries Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 88: GCC Countries Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 89: South Africa Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 90: South Africa Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 91: Rest of MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
Figure 92: Rest of MEA Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
Figure 93: MEA Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
Figure 94: MEA Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
Figure 95: MEA Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
